7281 - 7290 of 9039 Results
Title
Year
-
OPENTitle: The Effect of the COVID-19 Pandemic on People with Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 1365End Page: 1377Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202249Best OA location URL: https://escholarship.org/uc/item/231295zgCitation Count: 178
-
OPENTitle: Design considerations for C9orf72 disease prevention trialsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 11Start Page: 3844End Page: 3855Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf290Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf290/63960980/awaf290.pdfCitation Count: 2
-
OPENTitle: Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1αJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 2Start Page: 238End Page: 252.e7Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2017.12.028Best OA location URL: http://www.cell.com/article/S1097276517310079/pdfCitation Count: 165
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
-
OPENTitle: Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in VitroJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 3Issue #: 4Start Page: 4486End Page: 4493Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acsomega.7b01897Best OA location URL: https://doi.org/10.1021/acsomega.7b01897Citation Count: 41
-
OPENTitle: Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplexJournal Name: AutophagyPublisher: Informa UK LimitedVol: 20Issue #: 8Start Page: 1903End Page: 1905Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15548627.2024.2340399Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11262206/pdf/KAUP_20_2340399.pdfCitation Count: 15
-
OPENTitle: Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease PatientsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page: 38End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00038Best OA location URL: https://doi.org/10.3389/fnagi.2017.00038Citation Count: 63
-
OPENTitle: RIC3 variants are not associated with Parkinson's disease in French-Canadians and FrenchJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 53Issue #:Start Page: 194.e9End Page: 194.e11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.01.005Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2017.01.005Citation Count: 10
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum2016RESTRICTEDTitle: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 46Issue #:Start Page: 32End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003Citation Count: 26
-
OPENTitle: β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6354Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aaf3934Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5761666Citation Count: 435